POTASSIUM SULFATE

N/A

Manufactured by DNA Labs, Inc.

1,270 FDA adverse event reports analyzed

Last updated: 2026-04-15

About POTASSIUM SULFATE

POTASSIUM SULFATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by DNA Labs, Inc.. The most commonly reported adverse reactions for POTASSIUM SULFATE include DIARRHOEA, FATIGUE, NAUSEA, HEADACHE, PAIN. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for POTASSIUM SULFATE.

Top Adverse Reactions

DIARRHOEA41 reports
FATIGUE40 reports
NAUSEA40 reports
HEADACHE37 reports
PAIN37 reports
DRUG INEFFECTIVE36 reports
DIZZINESS31 reports
ARTHRALGIA29 reports
CONSTIPATION24 reports
PAIN IN EXTREMITY23 reports
FALL22 reports
MALAISE21 reports
ABDOMINAL PAIN UPPER20 reports
ASTHENIA20 reports
FEELING ABNORMAL20 reports
GAIT DISTURBANCE19 reports
INSOMNIA19 reports
MUSCLE SPASMS19 reports
OFF LABEL USE19 reports
DEPRESSION18 reports
DYSPNOEA18 reports
VOMITING18 reports
WEIGHT DECREASED18 reports
EYE PAIN17 reports
PRODUCT DOSE OMISSION ISSUE16 reports
PRURITUS16 reports
ALOPECIA15 reports
BLOOD PRESSURE INCREASED15 reports
DEATH15 reports
WEIGHT INCREASED15 reports
CONFUSIONAL STATE14 reports
DECREASED APPETITE14 reports
HYPOAESTHESIA14 reports
PARAESTHESIA14 reports
PNEUMONIA14 reports
BACK PAIN13 reports
FLUSHING13 reports
PLATELET COUNT DECREASED13 reports
RASH13 reports
TREMOR13 reports
CONDITION AGGRAVATED12 reports
VISION BLURRED12 reports
ANXIETY11 reports
DYSPEPSIA11 reports
ABDOMINAL DISCOMFORT10 reports
ABDOMINAL PAIN10 reports
BALANCE DISORDER10 reports
MIGRAINE10 reports
MULTIPLE SCLEROSIS RELAPSE10 reports
PRODUCT SUBSTITUTION ISSUE10 reports
PYREXIA10 reports
COVID 199 reports
HOT FLUSH9 reports
PERIPHERAL SWELLING9 reports
PRODUCT DOSE OMISSION9 reports
ANAEMIA8 reports
BLOOD GLUCOSE INCREASED8 reports
CHILLS8 reports
NEUROPATHY PERIPHERAL8 reports
PALPITATIONS8 reports
URTICARIA8 reports
VISUAL IMPAIRMENT8 reports
CHEST PAIN7 reports
CHRONIC KIDNEY DISEASE7 reports
CONTUSION7 reports
DEHYDRATION7 reports
DRUG DOSE OMISSION7 reports
INTENTIONAL PRODUCT MISUSE7 reports
MACULAR DEGENERATION7 reports
MEMORY IMPAIRMENT7 reports
NASOPHARYNGITIS7 reports
PETECHIAE7 reports
PLATELET COUNT ABNORMAL7 reports
SOMNOLENCE7 reports
ARTHRITIS6 reports
BURNING SENSATION6 reports
DRUG INTOLERANCE6 reports
EPISTAXIS6 reports
GASTROINTESTINAL DISORDER6 reports
ILLNESS6 reports
JOINT SWELLING6 reports
MUSCULAR WEAKNESS6 reports
MYALGIA6 reports
OROPHARYNGEAL PAIN6 reports
PLATELET DISORDER6 reports
PRODUCT USE ISSUE6 reports
SEIZURE6 reports
SEPSIS6 reports
THERAPY CESSATION6 reports
ACUTE KIDNEY INJURY5 reports
CATARACT5 reports
COUGH5 reports
DRUG HYPERSENSITIVITY5 reports
FEELING HOT5 reports
GASTROOESOPHAGEAL REFLUX DISEASE5 reports
HAEMORRHAGE5 reports
HYPERSENSITIVITY5 reports
INFLUENZA LIKE ILLNESS5 reports
JOINT STIFFNESS5 reports
MUSCULOSKELETAL STIFFNESS5 reports

Report Outcomes

Out of 564 classified reports for POTASSIUM SULFATE:

Serious 58.2%Non-Serious 41.8%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female375 (69.7%)
Male163 (30.3%)

Reports by Age

Age 7019 reports
Age 6618 reports
Age 6516 reports
Age 5815 reports
Age 6815 reports
Age 7415 reports
Age 7514 reports
Age 6913 reports
Age 7213 reports
Age 7112 reports
Age 7312 reports
Age 6111 reports
Age 6411 reports
Age 7611 reports
Age 8110 reports
Age 529 reports
Age 569 reports
Age 829 reports
Age 548 reports
Age 628 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with POTASSIUM SULFATE?

This profile reflects 1,270 FDA FAERS reports that mention POTASSIUM SULFATE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for POTASSIUM SULFATE?

Frequently reported terms in FAERS include DIARRHOEA, FATIGUE, NAUSEA, HEADACHE, PAIN, DRUG INEFFECTIVE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures POTASSIUM SULFATE?

Labeling and FAERS entries often list DNA Labs, Inc. in connection with POTASSIUM SULFATE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.